Skip to content

Merck & Co. MRK Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Gross margin73.9%-0.9pp74.8%-2.4pp77.2%+0.6pp76.6%+0.2pp76.4%+0.1pp
Net margin13.6%-14.5pp28.1%-1.6pp29.6%+3.8pp25.8%-1.5pp27.3%+0.6pp
EBITDA margin22.4%-14.7pp37.1%-0.1pp37.2%+3.8pp33.4%-1.4pp34.8%+0.5pp
Free cash flow margin21.5%+2.4pp19%-1.3pp20.3%-2.8pp23.1%-3.5pp26.7%-1.5pp
Returns
Return on equity19%-17.9pp36.9%-2.6pp39.5%+4.1pp35.4%-3.9pp39.3%-1.5pp
Return on assets7.3%-7.0pp14.4%-1.0pp15.4%+1.2pp14.3%-1.5pp15.8%+0.5pp
Return on invested capital10.8%-11.4pp22.2%-3.6pp25.8%+4.1pp21.8%-1.9pp23.6%-0.5pp
Efficiency
Asset turnover0.5×0.0×0.5×0.0×0.5×0.0×0.6×0.0×0.6×0.0×
Inventory turnover3.2×-0.1×3.3×+0.2×3.1×-0.5×3.6×-0.2×3.8×-0.2×
Liquidity
Current ratio1.3×-0.2×1.5×-0.1×1.7×+0.2×1.4×0.0×1.4×0.0×
Quick ratio1.1×-0.3×1.3×-0.1×1.5×+0.2×1.2×0.0×1.2×0.0×
Cash ratio0.2×-0.3×0.5×-0.1×0.6×+0.3×0.3×0.0×0.3×-0.1×
Leverage
Debt-to-equity1.1×+0.1×+0.2×0.8×+0.1×0.8×0.0×0.7×-0.1×
Debt-to-assets0.4×0.0×0.4×+0.1×0.3×0.0×0.3×0.0×0.3×0.0×
Net debt / EBITDA+1.4×1.6×+0.6×-0.3×1.4×+0.1×1.2×0.0×
Valuation
Market capitalization$297.4B+13.8%$261.26B+24.6%$209.64B+3.9%$201.69B-11.0%$226.74B-9.9%
Enterprise value$341.11B+13.9%$299.36B+27.8%$234.18B+1.6%$230.45B-9.3%$254.17B-8.9%
Price / earnings33.3×+19.0×14.3×+3.3×11×-1.3×12.3×-0.7×13×-1.7×
Price / sales4.5×+0.5×+0.8×3.3×+0.1×3.2×-0.4×3.5×-0.4×
Price / book6.5×+1.5×+0.9×-0.1×4.1×-0.6×4.7×-0.7×
EV / EBITDA23.1×+10.7×12.4×+2.6×9.8×-1.0×10.8×-0.6×11.4×-1.2×
EV / sales5.2×+0.6×4.6×+1.0×3.6×0.0×3.6×-0.4×-0.4×
Free cash flow yield4.7%0.0pp4.7%-1.5pp6.2%-1.1pp7.3%-0.2pp7.5%+0.3pp
Earnings yield3%-4.0pp7%-2.1pp9.1%+0.9pp8.1%+0.4pp7.7%+0.9pp
Dividend yield2.8%-0.4pp3.1%-0.7pp3.9%-0.1pp4%+0.5pp3.5%+0.4pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Merck & Co.'s ratios come from?
Every ratio is computed from Merck & Co.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.